دورية أكاديمية
Yellow nail syndrome in anti-SSA and anti-SSB positive primary Sjögren's syndrome.
العنوان: | Yellow nail syndrome in anti-SSA and anti-SSB positive primary Sjögren's syndrome. |
---|---|
المؤلفون: | D'Adamo LJ; Department of Internal Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia laura.dadamo2@health.qld.gov.au., Oh Y; Department of Rheumatology, Redcliffe Hospital, Brisbane, Queensland, Australia.; Redcliffe Northside Rheumatology, Brisbane, Queensland, Australia., Young L; Department of Rheumatology, Redcliffe Hospital, Brisbane, Queensland, Australia.; Redcliffe Northside Rheumatology, Brisbane, Queensland, Australia. |
المصدر: | BMJ case reports [BMJ Case Rep] 2024 Aug 19; Vol. 17 (8). Date of Electronic Publication: 2024 Aug 19. |
نوع المنشور: | Case Reports; Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 101526291 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-790X (Electronic) Linking ISSN: 1757790X NLM ISO Abbreviation: BMJ Case Rep Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: London : BMJ Pub. Group |
مواضيع طبية MeSH: | Sjogren's Syndrome*/complications , Sjogren's Syndrome*/immunology , Sjogren's Syndrome*/drug therapy , Sjogren's Syndrome*/diagnosis , Yellow Nail Syndrome*/diagnosis, Humans ; Female ; Adult ; Antibodies, Antinuclear/blood ; Antibodies, Antinuclear/immunology |
مستخلص: | Yellow nail syndrome (YNS) is a rare, acquired condition, characterised by at least two of the three clinical criteria: nail changes, respiratory tract disease and lymphoedema. Currently, the aetiology of YNS remains unknown; however, it is believed to be caused by impaired lymphatic drainage. Currently, there remain no definitive treatment options available and no prospective trials evaluating this. Management includes supportive care and symptomatic treatment. The presence of YNS has been described alongside various conditions, including autoimmune diseases, malignancies and drug exposures. To strengthen the literature on this topic, we present the case of a female patient with a history of anti-SSA and anti-SSB positive primary Sjögren's syndrome, who developed YNS in the immediate postpartum period. Competing Interests: Competing interests: None declared. (© BMJ Publishing Group Limited 2024. No commercial re-use. See rights and permissions. Published by BMJ.) |
فهرسة مساهمة: | Keywords: Rheumatology; Sjogren's syndrome |
المشرفين على المادة: | 0 (Antibodies, Antinuclear) 0 (SS-A antibodies) |
تواريخ الأحداث: | Date Created: 20240819 Date Completed: 20240819 Latest Revision: 20240927 |
رمز التحديث: | 20240927 |
DOI: | 10.1136/bcr-2024-260614 |
PMID: | 39159977 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1757-790X |
---|---|
DOI: | 10.1136/bcr-2024-260614 |